Suchergebnisse - "Cil, Timucin"

PubPharm (95)

11

Efficacy and safety of the proposed bevacizumab biosimilar BAT1706 compared with reference bevacizumab in patients with advanced nonsquamous non‐small cell lung cancer : A randomized, double‐blind, phase III study

enthalten in: Cancer Medicine | 2023

von Chen, L. | Rangel, J. | Cil, T. | +15

12

Panitumumab Associated Acute Pancreatitis

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2022

von Arbag, H. | Sumbul, H. | Buyuksimsek, M. | +7

13

Evaluation of antibody response after two doses of the Sinovac vaccine and the potential need for booster doses in cancer patients

enthalten in: Journal of medical virology | 2022

von Ata, S. | Cil, T. | Duman, B. | +1

14

Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer

enthalten in: The New England journal of medicine | 2022

von Forde, P. | Spicer, J. | Lu, S. | +127

CommentIn: N Engl J Med. 2022 May 26;386(21):2050-2051. - PMID 35403840

15

Proton pump inhibitors may reduce the efficacy of ribociclib and palbociclib in metastatic breast cancer patients based on an observational study

enthalten in: BMC cancer | 2022

von Eser, K. | Önder, A. | Sezer, E. | +8

16

Proton pump inhibitors may reduce the efficacy of ribociclib and palbociclib in metastatic breast cancer patients based on an observational study

enthalten in: BMC cancer | 2022

von Eser, K. | Önder, A. | Sezer, E. | +8

17

Proton pump inhibitors may reduce the efficacy of ribociclib and palbociclib in metastatic breast cancer patients based on an observational study

enthalten in: BMC cancer | 2022

von Eser, K. | Önder, A. | Sezer, E. | +8

18

Prognostic Importance of Inflammatory Indexes in Patients Treated by Pazopanib for Soft Tissue Sarcoma

enthalten in: Clinical laboratory | 2022

von Koseci, T. | Haksoyler, V. | Olgun, P. | +4

19

Evaluation of antibody response after two doses of the Sinovac vaccine and the potential need for booster doses in cancer patients

enthalten in: Journal of Medical Virology | 2022

von Ata, S. | Cil, T. | Duman, B. | +1

20

Proton pump inhibitors may reduce the efficacy of ribociclib and palbociclib in metastatic breast cancer patients

enthalten in: ResearchSquare.com | 2021

von ESER, K. | ÖNDER, A. | SEZER, E. | +8